Actipatch IS The New But Substantially Better Aspi
Post# of 7791
Big Pharma Could Have Bought This Cheap For $300 Million.
Not NOW!!
And The Market Cap Is Only About $34 Million.
I Have Seen This Product And Its Future For A LONG Time.
Many False Starts, NOT THIS TIME!!
Signed Deals!!
CVS Screwed Up. They Could Have Been First And Made A Lot Of Money.
Had Biel Accepted That Deal All What Is Coming Would NOT Have Been As
Profitable As This All Will Be!!
Biel No Longer Needs Defending!!
The Monster Is Emerging!!